+1 Recommend
1 collections
      • Record: found
      • Abstract: found
      • Article: found

      A 12-Year-Old Girl with Hemolytic Uremic Syndrome as Initial Symptom of Systemic Lupus erythematosus and a Literature Review

      Read this article at

          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.


          We describe a 12-year-old girl with systemic lupus erythematosus (SLE) who first presented with an atypical hemolytic uremic syndrome (HUS) associated with hypocomplementemia, and compare the clinical manifestations and prognosis between SLE patients with HUS and thrombotic thrombocytopenic purpura in the reported literature. Diagnoses were based on renal failure, hemolytic anemia, and thrombocytonemia, including the observation of fragmented red blood cells, hypocomplementemia and on the American College of Rheumatology criteria for SLE. Cocktail therapy may have been effective against the pathological condition of SLE. In 4 patients with SLE and HUS, prednisolone and immunosuppressive drugs were administered, and none of the patients suffered from chronic renal insufficiency. The prognosis for SLE patients with HUS is good. These findings suggest that SLE should be suspected in any HUS patient presenting with hemolytic anemia, thrombocytopenia, acute renal failure and hypocomplementemia, and the therapeutic response and prognosis for SLE with HUS are good.

          Related collections

          Most cited references 1

          • Record: found
          • Abstract: found
          • Article: found

          Hemolytic-Uremic Syndrome Superimposed on Chronic Lupus Nephritis


            Author and article information

            Am J Nephrol
            American Journal of Nephrology
            S. Karger AG
            December 2002
            07 October 2002
            : 22
            : 5-6
            : 576-580
            Department of Pediatrics, Fukushima Medical University School of Medicine, Fukushima, Japan
            65286 Am J Nephrol 2002;22:576–580
            © 2002 S. Karger AG, Basel

            Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher. Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug. Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

            Page count
            Figures: 2, Tables: 3, References: 9, Pages: 5
            Self URI (application/pdf): https://www.karger.com/Article/Pdf/65286
            Case Report

            Cardiovascular Medicine, Nephrology

            Systemic lupus erythematosus, Hemolytic uremic syndrome


            Comment on this article